Long-term oxygen therapy & oxygen assessment
LTOT · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Long-term oxygen therapy improves survival in chronic hypoxaemic respiratory failure (most evidence in COPD) when used >=15 hours/day. Careful assessment of resting arterial oxygenation during a stable period is required, as oxygen for mild/exertional-only desaturation does not improve survival.
Red flags
- Continued smoking (fire and burn risk)
- Rising CO2 / respiratory acidosis on oxygen
- Decompensated cor pulmonale
- Worsening hypoxaemia despite therapy
Assessment
Differential diagnosis
- COPD with chronic hypoxaemia
- Interstitial lung disease
- Pulmonary hypertension
- Chronic heart failure
- Chest-wall/neuromuscular disease
Investigations
- Arterial blood gases on air when clinically stable (repeated to confirm)
- Oximetry at rest and on exertion
- Assessment for hypercapnia and risk of CO2 retention
- Carboxyhaemoglobin (confirm smoking cessation and fire-risk safety)
- Echocardiography for cor pulmonale; full disease assessment
Management
- Ensure the patient is clinically stable for >=8 weeks and on optimal therapy before assessing
- Measure resting arterial blood gases on air (confirm with a repeat)
- Qualify for LTOT if PaO2 <=7.3 kPa, or <=8.0 kPa with cor pulmonale/polycythaemia/nocturnal hypoxaemia
- Assess for hypercapnia and titrate oxygen to a safe target saturation
- Confirm the patient does not smoke and counsel on fire and burn risk
- Prescribe concentrator oxygen for >=15 hours per day
- Arrange ambulatory oxygen only where it corrects exertional desaturation and improves exercise
- Do not prescribe oxygen for breathlessness without hypoxaemia
- Provide safety education and home-fire-risk assessment
- Review blood gases after initiation and reassess regularly
Drugs & doses
Oxygen via concentrator titrated to target SpO2 (e.g. 90-92% in those at risk of retention)
Ambulatory oxygen for exertional desaturation where benefit demonstrated
Optimise bronchodilators and treat the underlying disease
Smoking-cessation pharmacotherapy (oxygen is contraindicated in continuing smokers due to fire risk)
Disposition
Home oxygen assessment service; respiratory follow-up with repeat gases; fire-safety assessment.
Complications & pitfalls
- Burns/fire from smoking on oxygen
- CO2 retention and acidosis
- Dependence and reduced mobility
- Nasal mucosal drying and discomfort
Exam pearls
- Oxygen improves survival only in chronic resting hypoxaemia used >=15 h/day, not for isolated exertional desaturation
- Never prescribe home oxygen to a current smoker due to fire risk
- Assess during clinical stability, not during or soon after an exacerbation
- Breathlessness without hypoxaemia is not an indication for oxygen — consider other measures
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.